- Selecting first-line bevacizumab-containing therapy for advanced brea…
Number of the records: 1  

Selecting first-line bevacizumab-containing therapy for advanced breast cancer: TURANDOT risk factor analyses

  1. Selecting first-line bevacizumab-containing therapy for advanced breast cancer: TURANDOT risk factor analyses. In Onkológia. ISSN 1336-8176. Bratislava : SOLEN, 2015, 2015, roč. 10, č. 6, s. 402-403.
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.

Accept allSettingsReject all